Quality of life of glaucoma patients under medical therapy with different prostaglandins

Código QR

Quality of life of glaucoma patients under medical therapy with different prostaglandins

Ricardo Augusto Paletta Guedes,1&ndash;3 Vanessa Maria Paletta Guedes,1&ndash;3, Sirley Maria Freitas,2 Alfredo Chaoubah11Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil; 2Paletta Guedes Ophthalmological Center, Juiz de Fora, MG, Brazil; 3Santa Casa de Miseric&...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Paletta Guedes RA, Paletta Guedes VM, Freitas SM, Chaoubah A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/284016c22dcf4a4098f75a923a4da20f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Utility values for glaucoma in Brazil and their correlation with visual function
por: Paletta Guedes RA, et al.
Publicado: (2014)

Does the type of treatment have an influence on utility values in a glaucoma population?
por: Paletta Guedes RA, et al.
Publicado: (2015)

Two-Year Comparative Outcomes of First- and Second-Generation Trabecular Micro-Bypass Stents with Cataract Surgery
por: Paletta Guedes RA, et al.
Publicado: (2021)

Comments on the Article by Arnljots and Economou [Letter]
por: Paletta Guedes RA
Publicado: (2021)

Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs
por: Schmier JK, et al.
Publicado: (2014)

Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients
por: Michael B Horsley, et al.
Publicado: (2009)

Paired-eye comparison of medical therapies for glaucoma
por: Alfred M Solish, et al.
Publicado: (2010)

Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
por: Jordana K Schmier, et al.
Publicado: (2010)

Quality of life following glaucoma surgery: canaloplasty versus trabeculectomy
por: Klink T, et al.
Publicado: (2014)

Considerations in glaucoma therapy: fixed combinations versus their component medications
por: Eve J Higginbotham
Publicado: (2009)

Pediatric glaucoma medical therapy: who more accurately reports medication adherence, the caregiver or the child?
por: Moore DB, et al.
Publicado: (2015)

Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension
por: Lorenz K, et al.
Publicado: (2011)

Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis
por: Oghenowede Eyawo, et al.
Publicado: (2009)

Managing adverse effects of glaucoma medications
por: Inoue K
Publicado: (2014)

Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma
por: Mizoguchi T, et al.
Publicado: (2011)

Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy
por: J Charles Henry, et al.
Publicado: (2008)

Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months
por: Kenji Inoue, et al.
Publicado: (2011)

Intensity of side effects of topical glaucoma medication and its influence on adherence behavior in patients with glaucoma
por: Yu AL, et al.
Publicado: (2014)

Prostaglandin-associated periorbitopathy in latanoprost users
por: Nakakura S, et al.
Publicado: (2014)

The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration
por: Keith Evans, et al.
Publicado: (2009)

Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database
por: Philippe Denis, et al.
Publicado: (2008)

Patient satisfaction with glaucoma therapy: reality or myth?
por: Lemij HG, et al.
Publicado: (2015)

Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications
por: Takeo Fukuchi, et al.
Publicado: (2010)

Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center
por: Griffith JF, et al.
Publicado: (2015)

Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
por: Costa VP, et al.
Publicado: (2012)

First experience with BAK-free travoprost 0.004% in topical glaucoma medication
por: Gado AS, et al.
Publicado: (2011)

Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherence
por: Paul F Cook, et al.
Publicado: (2010)

Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
por: Cvenkel B, et al.
Publicado: (2015)

Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations
por: Fukuda M, et al.
Publicado: (2013)

Successful treatment of prostaglandin-induced cystoid macular edema with subtenon triamcinolone
por: Matsuura K, et al.
Publicado: (2012)

The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
por: Radcliffe NM
Publicado: (2014)

Secondary pigmentary glaucoma in patients with underlying primary pigment dispersion syndrome
por: Sivaraman KR, et al.
Publicado: (2013)

Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides
por: Scott D Smid
Publicado: (2009)

Long-term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma
por: Tarek A Shazly, et al.
Publicado: (2010)

Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost
por: Hommer A, et al.
Publicado: (2011)

Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate
por: Jaime Pablo Kelly Rigollet, et al.
Publicado: (2011)

First-year treatment costs among new initiators of topical prostaglandin analogs
por: Jordana K Schmier, et al.
Publicado: (2009)

Evaluation of the relationship between quality of vision and visual function in Japanese glaucoma patients
por: Hideko Sawada, et al.
Publicado: (2011)

Continuous 24-hour ocular dimensional profile recording in medically treated normal-tension glaucoma
por: Lee JWY, et al.
Publicado: (2015)

Virtual glaucoma clinics: patient acceptance and quality of patient education compared to standard clinics
por: Court JH, et al.
Publicado: (2015)